Published in Ann Surg on December 01, 2004
Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg (2012) 4.70
Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg (2005) 2.28
Extended esophagectomy in elderly patients with esophageal cancer: minor effect of age alone in determining the postoperative course and survival. Ann Surg Oncol (2010) 2.13
Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg (2007) 1.98
Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer. World J Surg (2012) 1.51
Lymphadenectomy along the left recurrent laryngeal nerve by a minimally invasive esophagectomy in the prone position for thoracic esophageal cancer. Surg Endosc (2010) 1.34
Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. Ann Surg Oncol (2012) 1.29
Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis. J Gastroenterol (2011) 1.26
The first series of completely robotic esophagectomies with three-field lymphadenectomy: initial experience. Surg Endosc (2007) 1.21
Transhiatal esophagectomy in a high volume institution. World J Surg Oncol (2008) 1.03
The "best operation" for esophageal cancer? Ann Thorac Surg (2010) 1.03
Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol (2008) 0.95
The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Br J Cancer (2012) 0.94
Neoadjuvant treatment for esophageal squamous cell carcinoma. World J Gastrointest Oncol (2014) 0.94
Minimally invasive esophagectomy for cancer: laparoscopic transhiatal procedure or thoracoscopy in prone position followed by laparoscopy? Surg Endosc (2007) 0.89
A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol (2012) 0.88
Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy. World J Surg (2013) 0.87
Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbecks Arch Surg (2010) 0.87
Current status and future perspectives on minimally invasive esophagectomy. Korean J Thorac Cardiovasc Surg (2013) 0.84
Extended lymphadenectomy in esophageal cancer is debatable. World J Surg (2013) 0.83
Solitary nodal recurrence in the dorsal area of the thoracic aorta after a curative resection of esophageal cancer: report of two cases. Surg Today (2007) 0.83
Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection. BMC Surg (2014) 0.83
Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma. Mol Clin Oncol (2013) 0.83
Two different surgical approaches in the treatment of adenocarcinoma at the gastroesophageal junction. World J Surg (2008) 0.82
Computed tomography-based distribution of involved lymph nodes in patients with upper esophageal cancer. Curr Oncol (2015) 0.81
Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma. BMC Cancer (2012) 0.81
Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer. Surg Endosc (2013) 0.81
Extended lymphadenectomy in esophageal cancer is crucial. World J Surg (2013) 0.81
Comparison between different reconstruction routes in esophageal squamous cell carcinoma. World J Gastroenterol (2012) 0.80
Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis (2014) 0.79
Preoperative risk analysis--a reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg (2006) 0.78
Post-esophagectomy tube feeding: a retrospective comparison of jejunostomy and a novel gastrostomy feeding approach. PLoS One (2014) 0.78
Robot-assisted thoracolaparoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc (2007) 0.78
Surgical anatomy of the supracarinal esophagus based on a minimally invasive approach: vascular and nervous anatomy and technical steps to resection and lymphadenectomy. Surg Endosc (2016) 0.78
A novel method for lymphadenectomy along the left laryngeal recurrent nerve during thoracoscopic esophagectomy for esophageal carcinoma. J Thorac Dis (2016) 0.77
Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer. J Thorac Cardiovasc Surg (2016) 0.77
Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status. World J Gastroenterol (2015) 0.77
Outcomes of thoracoscopic esophagectomy in prone position with laparoscopic gastric mobilization for esophageal cancer. Langenbecks Arch Surg (2016) 0.76
How radical should surgery be for early esophageal cancer? World J Surg (2011) 0.76
Minimally invasive esophagectomy: thoracoscopic esophageal mobilization for esophageal cancer with the patient in prone position. Surg Endosc (2011) 0.76
Lymphatic spreading and lymphadenectomy for esophageal carcinoma. World J Gastrointest Surg (2016) 0.75
Evidence-Based Operative Details in Esophageal Cancer Treatment: Surgical Approach, Lymphadenectomy, Anastomosis. Viszeralmedizin (2015) 0.75
Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer. World J Surg Oncol (2016) 0.75
Neck dissection for thoracic esophageal squamous cell carcinoma. Int J Surg Oncol (2012) 0.75
Esophageal Cancer: Current Options for Therapeutic Management. Gastrointest Tumors (2014) 0.75
Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field). Ann Cardiothorac Surg (2017) 0.75
Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer. Clin Exp Gastroenterol (2009) 0.75
Three-field lymph node dissection in treating the esophageal cancer. J Thorac Dis (2016) 0.75
Cervical lymph node metastases from remote primary tumor sites. Head Neck (2015) 0.75
Minimally invasive esophagectomy in the elderly. Indian J Surg Oncol (2013) 0.75
Minimally invasive esophagectomy for esophageal cancer according to the location of the tumor: Experience of 251 patients. Ann Med Surg (Lond) (2017) 0.75
Penile and intramuscular metastases from esophageal squamous cell carcinoma: A rare case report and review of the literature. Can Urol Assoc J (2014) 0.75
Current and evolving surgical strategies in thoracic oncology. Indian J Surg Oncol (2013) 0.75
Pattern of lymph node metastases of squamous cell esophageal cancer based on the anatomical lymphatic drainage system: efficacy of lymph node dissection according to tumor location. J Thorac Dis (2017) 0.75
Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes. Langenbecks Arch Surg (2016) 0.75
Western strategy for EGJ carcinoma. Gastric Cancer (2016) 0.75
Periodontal and endodontic pathology delays extraction socket healing in a canine model. J Periodontal Implant Sci (2017) 0.75
Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis (2017) 0.75
Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg (1994) 3.80
Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg (1991) 3.00
Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology (1991) 2.54
Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg (1992) 2.43
A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg (1998) 2.09
Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg (2002) 1.96
Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg (1993) 1.56
Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg (1997) 1.53
The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg (2000) 1.48
Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg (1998) 1.29
Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg (1994) 1.11
Extended radical esophagectomy for superficially invasive carcinoma of the esophagus. Surgery (1999) 1.04
Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy Br J Surg (2000) 1.02
Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg (2003) 0.99
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77
Microscopic colitis with giant cells. Histopathology (2002) 2.64
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol (2002) 2.60
Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg (1992) 2.43
Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc (2008) 2.29
Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg (2003) 2.15
Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol (2009) 1.72
Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol (1997) 1.69
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J (1999) 1.51
Pulmonary sequestration: a comparison between pediatric and adult patients. Eur J Cardiothorac Surg (2001) 1.46
Anastomotic complications after esophagectomy. Dig Surg (2002) 1.41
[Physiological effects of lung reduction surgery: the contribution of an animal model of emphysema]. Rev Mal Respir (2003) 1.39
Need for objective and reproducible criteria in histopathological assessment of total mesorectal excision specimens: lessons from a national improvement project. Colorectal Dis (2013) 1.39
Imaging of cholelithiasis: what does the surgeon need? Abdom Imaging (2001) 1.38
Sleeve lobectomy for non-small cell lung cancer. Acta Chir Belg (2004) 1.37
Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes. Matrix Biol (2001) 1.32
Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma. Surg Endosc (2007) 1.28
Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes. Matrix Biol (1998) 1.27
A new approach to the validation of tissue microarrays. J Pathol (2006) 1.23
Glycoproteins of coated pits, cell junctions, and the entire cell surface revealed by monoclonal antibodies and immunoelectron microscopy. J Cell Biol (1983) 1.21
Tumor cell implantation after colonoscopy with biopsies in a patient with rectal cancer: report of a case. Dis Colon Rectum (1997) 1.20
The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology (1986) 1.18
Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg (1996) 1.16
Lessons learned from the European thoracic surgery database: the Composite Performance Score. Eur J Surg Oncol (2010) 1.16
Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol (1992) 1.16
Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. Hepatogastroenterology (1999) 1.15
Is calcifying fibrous pseudotumor a late sclerosing stage of inflammatory myofibroblastic tumor? Am J Surg Pathol (1999) 1.14
Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg (1994) 1.14
The effects of 5-HT on cholinergic contraction in human airways in vitro. Eur Respir J (1999) 1.13
Egg cortical granule N-acetylglucosaminidase is required for the mouse zona block to polyspermy. J Cell Biol (1993) 1.12
Is ileoscopy with biopsy worthwhile in patients presenting with symptoms of inflammatory bowel disease? Am J Gastroenterol (1998) 1.11
Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology (1992) 1.08
Thoracoscopic thymectomy in autoimmune myasthesia: results of left-sided approach. Ann Thorac Surg (2000) 1.06
Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg (1999) 1.04
Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity. J Pathol (2006) 1.04
Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction. Gastrointest Endosc (1997) 1.02
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg (2000) 1.00
On the existence and location of cardiac mucosa: an autopsy study in embryos, fetuses, and infants. Gut (2003) 1.00
Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg (1997) 1.00
Crohn's disease and intestinal endometriosis: an intriguing co-existence. Eur J Gastroenterol Hepatol (2000) 0.99
[Functioning of the tube stomach following esophagus resection for carcinoma]. Ned Tijdschr Geneeskd (1993) 0.98
Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis (1999) 0.98
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol (2004) 0.98
Early and late functional results in patients with intrathoracic gastric replacement after oesophagectomy for carcinoma. Eur J Cardiothorac Surg (1992) 0.97
Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital. Med Mycol (2010) 0.97
Multifocal epithelioid angiosarcoma of the small intestine. Virchows Arch (2000) 0.97
A pancreatic mucinous cystadenoma in a man with mesenchymal stroma, expressing oestrogen and progesterone receptors. Virchows Arch (1998) 0.96
Guidelines Belgian Society of Pneumology. Guidelines on the management of spontaneous pneumothorax. Acta Chir Belg (2005) 0.95
Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction. Ann Surg (2008) 0.95
Bacterial biofilm within diseased pancreatic and biliary tracts. Gut (2005) 0.95
Long-term potentiation: studies in the hippocampal slice. J Neurosci Methods (1989) 0.94
The relative impact of legislative incentives on multi-organ donation rates in Europe. Transplant Proc (1995) 0.93
Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer. Br J Surg (2012) 0.93
Bronchogenic cysts: a review of 20 cases. Eur J Cardiothorac Surg (1996) 0.93
Incentive spirometry does not enhance recovery after thoracic surgery. Crit Care Med (2000) 0.92
The prognostic relevance of tumor hypoxia markers in resected carcinoma of the gallbladder. Eur J Surg Oncol (2011) 0.92
Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. Surg Oncol (2001) 0.92